Publication: Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis
dc.contributor.author | Ristić, Gorica G. (57196975326) | |
dc.contributor.author | Subota, Vesna (16319788700) | |
dc.contributor.author | Stanisavljević, Dejana (23566969700) | |
dc.contributor.author | Vojvodić, Danilo (6603787420) | |
dc.contributor.author | Ristić, Arsen D. (7003835406) | |
dc.contributor.author | Glišić, Branislava (8106039600) | |
dc.contributor.author | Petronijević, Milan (6602635159) | |
dc.contributor.author | Stefanović, Dušan Z. (7006269465) | |
dc.date.accessioned | 2025-06-12T13:11:44Z | |
dc.date.available | 2025-06-12T13:11:44Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objective: To explore glucose metabolism in rheumatoid arthritis (RA) and its association with insulin resistance (IR) risk factors and disease activity indicators, including matrix metalloproteinase-3 (MMP3). Methods: This single-center study included 127 non-diabetic subjects: 90 RA patients and 37 matched controls. IR-related risk factors, disease activity (DAS28-ESR/CRP), concentrations of inflammation markers, MMP3, glucose, specific insulin, and C-peptide (a marker of β-cell secretion) were determined. Homeostasis Model Assessment was used to establish insulin resistance (HOMA2-IR) and sensitivity (HOMA2-%S). Associations of HOMA2 indices with IR-related risk factors, inflammation markers, and RA activity were tested using multiple regression analyses. Results: RA patients had significantly increased HOMA2-IR index than controls. In the RA group, multivariate analysis revealed DAS28-ESR, DAS28-CRP, tender joint counts, patient’s global assessment, and MMP3 level as significant positive predictors for HOMA2-IR (β = 0.206, P = 0.014; β = 0.192, P = 0.009; β = 0.121, P = 0.005; β = 0.148, P = 0.007; β = 0.075, P = 0.025, respectively), and reciprocal negative for HOMA2-%S index. According to the value of the coefficient of determination (R2), DAS28-ESR ≥ 5.1 has the largest proportion of variation in both HOMA2-IR indices. DAS28-ESR ≥ 5.1 and ESR were independent predictors for increased C-peptide concentration (β = 0.090, P = 0.022; β = 0.133, P = 0.022). Despite comparability regarding all IR-related risk factors, patients with DAS28-ESR ≥ 5.1 had higher HOMA2-IR than controls [1.7 (1.2–2.5) vs. 1.2 (0.8–1.4), P = 0.000]. There was no difference between patients with DAS28-ESR < 5.1 and controls [1.3 (0.9–1.9) vs. 1.2 (0.8–1.4), P = 0.375]. Conclusions: RA activity is an independent risk factor for impaired glucose metabolism. DAS28-ESR ≥ 5.1 was the main contributor to this metabolic disturbance, followed by MMP3 concentration, outweighing the impact of classic IR-related risk factors. © 2021, The Author(s). | |
dc.identifier.uri | https://doi.org/10.1186/s13075-021-02476-0 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103564801&doi=10.1186%2fs13075-021-02476-0&partnerID=40&md5=75f3f0aea431cda84b7b3eff56861544 | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/3898 | |
dc.subject | Insulin resistance | |
dc.subject | Matrix metalloproteinase-3 | |
dc.subject | Rheumatoid arthritis | |
dc.title | Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis | |
dspace.entity.type | Publication |